![Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay Guidance Manual - NCBI Bookshelf Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay Guidance Manual - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK553584/bin/assayinterference-Image011.jpg)
Figure 10, [Schematic of an antibody-based counter-screen...]. - Assay Guidance Manual - NCBI Bookshelf
![Establishing assays and small molecule screening facilities for Drug discovery programs - European Pharmaceutical Review Establishing assays and small molecule screening facilities for Drug discovery programs - European Pharmaceutical Review](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Figure_1-750x500.jpg)
Establishing assays and small molecule screening facilities for Drug discovery programs - European Pharmaceutical Review
![High-throughput screening assays for the identification of chemical probes | Nature Chemical Biology High-throughput screening assays for the identification of chemical probes | Nature Chemical Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnchembio.2007.17/MediaObjects/41589_2007_Article_BFnchembio200717_Fig1_HTML.jpg)
High-throughput screening assays for the identification of chemical probes | Nature Chemical Biology
![Counter-screen of three inhibitors. Concentration–response plots are... | Download Scientific Diagram Counter-screen of three inhibitors. Concentration–response plots are... | Download Scientific Diagram](https://www.researchgate.net/publication/317300506/figure/fig3/AS:513488676024320@1499436648384/Counter-screen-of-three-inhibitors-Concentration-response-plots-are-shown-for-three.png)
Counter-screen of three inhibitors. Concentration–response plots are... | Download Scientific Diagram
![Screen and counter screen protocol followed in virtual screening for... | Download Scientific Diagram Screen and counter screen protocol followed in virtual screening for... | Download Scientific Diagram](https://www.researchgate.net/publication/286674023/figure/fig2/AS:362316282515459@1463394341425/Figure-2-Screen-and-counter-screen-protocol-followed-in-virtual-screening-for-the.png)
Screen and counter screen protocol followed in virtual screening for... | Download Scientific Diagram
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE
![Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns | Semantic Scholar Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b014f7f77458b800186f95a4e4652371cc003e43/3-Figure1-1.png)
Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns | Semantic Scholar
![A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications - ScienceDirect A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2472555222067326-gr1.jpg)
A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications - ScienceDirect
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors | PLOS ONE
![Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021 Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021](https://journals.sagepub.com/cms/10.1177/24725552211008862/asset/images/large/10.1177_24725552211008862-fig1.jpeg)
Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021
![Figure 2, CID 1245700 was tested across a range of concentrations up to 10 μM in the primary assay and secondary counter screen, up to 25 μM in mammalian cytotoxicity assays, and Figure 2, CID 1245700 was tested across a range of concentrations up to 10 μM in the primary assay and secondary counter screen, up to 25 μM in mammalian cytotoxicity assays, and](https://www.ncbi.nlm.nih.gov/books/NBK280045/bin/ml406f4.jpg)
Figure 2, CID 1245700 was tested across a range of concentrations up to 10 μM in the primary assay and secondary counter screen, up to 25 μM in mammalian cytotoxicity assays, and
![High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex | Scientific Reports High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-53110-8/MediaObjects/41598_2019_53110_Fig1_HTML.png)
High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex | Scientific Reports
![Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays | Scientific Reports Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-75890-0/MediaObjects/41598_2020_75890_Fig1_HTML.png)
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays | Scientific Reports
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening | ACS Pharmacology & Translational Science
![Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds: Trends in Pharmacological Sciences Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/eb18b025-2106-4057-ace6-83e95544c2c1/gr1_lrg.jpg)
Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds: Trends in Pharmacological Sciences
![Development of an AlphaLISA protein-protein interaction assay to screen for re-purposed drugs as targeted disruptors | BMG LABTECH Development of an AlphaLISA protein-protein interaction assay to screen for re-purposed drugs as targeted disruptors | BMG LABTECH](https://www.bmglabtech.com/hubfs/Webseite/5_Resources/App%20Notes/6_App%20Notes%20350-399/AN357-Fig1.webp)